Federal contract award
75A50119C00071
ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | ASPR/ORM-SNS |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6515 — Medical and Surgical Instruments, Equipment, and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $857.6M |
| Current contract value | $857.6M |
| Potential contract value / ceiling | $857.6M |
| Start date | Aug 30, 2019 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2029 |
| Latest award activity | Jun 26, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 16 of 16 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 26, 2026 | P00015 | $52.8M | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) |
| Sep 5, 2025 | P00014 | $56.0M | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) |
| Dec 11, 2024 | P00013 | $-254.6K | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) |
| Jun 28, 2024 | P00012 | $100.0M | ADMINISTRATIVE ACTION |
| Apr 29, 2024 | P00011 | $0 | ADMINISTRATIVE ACTION |
| May 19, 2023 | P00010 | $120.0M | ADMINISTRATIVE ACTION |
| May 18, 2023 | P00009 | $-32.4K | ADMINISTRATIVE ACTION |
| Nov 21, 2022 | P00008 | $0 | ADMINISTRATIVE ACTION |
| Oct 6, 2022 | P00007 | $0 | ADMINISTRATIVE ACTION |
| Oct 25, 2021 | P00006 | $0 | EO14042 VAX EO |
| Sep 29, 2021 | P00005 | $0 | MODIFICATION TO EXCHANGE CANS |
| Jul 5, 2021 | P00004 | $182.2M | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) |
| Mar 24, 2021 | P00003 | $753.4K | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) |
| Oct 19, 2020 | P00002 | $0 | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) |
| May 28, 2020 | P00001 | $176.3M | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) |
| Aug 30, 2019 | 0 | $170.0M | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) |
Estimated positioning window
Sep 30, 2028 – Mar 30, 2029
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2029-09-30 (1071 days from calculation)
- +15 points
- 1 historical awards in this buyer and category group
- +0 points
- 16 recorded award transactions
- +10 points
- Latest award action: 2026-06-26
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.